Methods of preventing platelet activation
A method of preventing or reducing the occurrence of malondiadehyde and/or levuglandin protein modification in a subject in need thereof, comprising administering to said subject an effective amount of at least one γ-KA scavenger compound, or a pharmaceutically acceptable salt thereof.
1. A method of reducing the occurrence of malondiadehyde protein modification in a subject in need thereof, comprising:
identifying a subject with increased platelet activation;
administering to said subject a malondiadehyde adduct formation reducing amount of a compound of the following formula:
or a pharmaceutically acceptable salt thereof;
to thereby reduce said protein modification.
2. The method of claim 1 , wherein the compound is
3. The method of claim 1 , wherein the compound is selected from the following formula:
or a pharmaceutically acceptable salt thereof.